中国癌症杂志
中國癌癥雜誌
중국암증잡지
CHINA ONCOLOGY
2013年
12期
974-979
,共6页
Aurora-A%胰腺癌%放射敏感性
Aurora-A%胰腺癌%放射敏感性
Aurora-A%이선암%방사민감성
Aurora-A%Pancreatic cancer%Radiosensitivity
背景与目的:Aurora-A属于丝氨酸和苏氨酸蛋白激酶家族,其异常表达可导致肿瘤发生及其对放射线的抵抗,本研究旨在探讨Aurora-A与细胞放射敏感的相关性。方法:用Aurora-A激酶抑制剂处理Capan-1细胞,检测细胞增殖、锚定非依赖性生长和细胞周期及其周期相关蛋白的变化;处理的细胞同时用γ线照射,然后用流式细胞术检测细胞凋亡。结果:Aurora-A激酶抑制剂处理后,Capan-1细胞生长速度减慢,克隆形成率降低;Aurora-A抑制可引起细胞周期G1/S以及G2/M期转化阻滞,Cyclin D1、CDK2和CDK6表达下降。Aurora-A激酶抑制剂处理后可以提高放射线照射诱导的细胞凋亡率。结论:Aurora-A激酶抑制剂可抑制胰腺癌细胞增殖,阻滞细胞周期,促进细胞对放射线照射的敏感性。因此,Aurora-A可能是胰腺癌放射治疗增敏的靶向分子之一。
揹景與目的:Aurora-A屬于絲氨痠和囌氨痠蛋白激酶傢族,其異常錶達可導緻腫瘤髮生及其對放射線的牴抗,本研究旨在探討Aurora-A與細胞放射敏感的相關性。方法:用Aurora-A激酶抑製劑處理Capan-1細胞,檢測細胞增殖、錨定非依賴性生長和細胞週期及其週期相關蛋白的變化;處理的細胞同時用γ線照射,然後用流式細胞術檢測細胞凋亡。結果:Aurora-A激酶抑製劑處理後,Capan-1細胞生長速度減慢,剋隆形成率降低;Aurora-A抑製可引起細胞週期G1/S以及G2/M期轉化阻滯,Cyclin D1、CDK2和CDK6錶達下降。Aurora-A激酶抑製劑處理後可以提高放射線照射誘導的細胞凋亡率。結論:Aurora-A激酶抑製劑可抑製胰腺癌細胞增殖,阻滯細胞週期,促進細胞對放射線照射的敏感性。因此,Aurora-A可能是胰腺癌放射治療增敏的靶嚮分子之一。
배경여목적:Aurora-A속우사안산화소안산단백격매가족,기이상표체가도치종류발생급기대방사선적저항,본연구지재탐토Aurora-A여세포방사민감적상관성。방법:용Aurora-A격매억제제처리Capan-1세포,검측세포증식、묘정비의뢰성생장화세포주기급기주기상관단백적변화;처리적세포동시용γ선조사,연후용류식세포술검측세포조망。결과:Aurora-A격매억제제처리후,Capan-1세포생장속도감만,극륭형성솔강저;Aurora-A억제가인기세포주기G1/S이급G2/M기전화조체,Cyclin D1、CDK2화CDK6표체하강。Aurora-A격매억제제처리후가이제고방사선조사유도적세포조망솔。결론:Aurora-A격매억제제가억제이선암세포증식,조체세포주기,촉진세포대방사선조사적민감성。인차,Aurora-A가능시이선암방사치료증민적파향분자지일。
Background and purpose:Aurora-A is a member of serine/threonine kinase family. The abnormal expression of Aurora-A induces tumorigenesis and radioresistance. This study was aimed to investigate the association of Aurora-A with radioresistance. Methods: Capan-1 cells were treated with Aurora-A kinase inhibitor, and then used to test cell proliferation, anchorage independent assay, cell cycle, and cell cycle regulatory proteins. Treated cells were also used to detect cell apoptosis afterγ-irradiation. Results:Cell growth and colony number in soft agar were decreased after treatment with Aurora-A inhibitor. Treatment of cells with Aurora-A inhibitor also down-regulated the expression of Cyclin D1, CDK2 and CDK6 to induce cell cycle arrest at G1/S and G2/M phases, but promoted cell apoptosis afterγ-irradiation. Conclusion:Treatment of pancreatic cancer cells with Aurora-A kinase inhibitor blocks cell proliferation and cell cycle progression, and promotes sensitivity of cells to radiation. Thus, Aurora-A may be used as one of therapeutic targets to increase the sensitivity of pancreatic cancer radiotherapy.